---
figid: PMC9254539__12935_2022_2645_Fig2_HTML
figtitle: 'Lipid metabolism in tumor microenvironment: novel therapeutic targets'
organisms:
- NA
pmcid: PMC9254539
filename: 12935_2022_2645_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9254539/figure/Fig2/
number: F2
caption: Pathways of cholesterol synthesis and regulation of carcinogenetic signals.
  Scheme showing cholesterol synthetic pathways, carcinogenetic signaling regulation
  in mevalonate pathway, and the cholesterol oxygenated metabolites feedback on cholesterol
  synthesis and efflux/influx. PI3K/AKT/mTOR and mutant p53 activate the mevalonate
  pathway via upregulation of SREBP, while Statins and LXR can inhibit cholesterol
  synthesis. 27HC negatively feedbacks on cholesterol synthesis and efflux/influx
  but miR-33a decreases cholesterol efflux. MVK mevalonate kinase; MVD mevalonate diphosphate
  decarboxylase; PMVK phosphomevalonate kinase; FPPS farnesylpyrophosphate synthase;
  SQS squalene synthase; SQLE squalene epoxidase; LSS lanosterol synthase
papertitle: 'Lipid metabolism in tumor microenvironment: novel therapeutic targets.'
reftext: Xingkai Liu, et al. Cancer Cell Int. 2022;22:224.
year: '2022'
doi: 10.1186/s12935-022-02645-4
journal_title: Cancer Cell International
journal_nlm_ta: Cancer Cell Int
publisher_name: BioMed Central
keywords: Lipid | Fatty acid | Cholesterol | Lipid metabolism | Tumor microenvironment
automl_pathway: 0.9524765
figid_alias: PMC9254539__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC9254539__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9254539__12935_2022_2645_Fig2_HTML.html
  '@type': Dataset
  description: Pathways of cholesterol synthesis and regulation of carcinogenetic
    signals. Scheme showing cholesterol synthetic pathways, carcinogenetic signaling
    regulation in mevalonate pathway, and the cholesterol oxygenated metabolites feedback
    on cholesterol synthesis and efflux/influx. PI3K/AKT/mTOR and mutant p53 activate
    the mevalonate pathway via upregulation of SREBP, while Statins and LXR can inhibit
    cholesterol synthesis. 27HC negatively feedbacks on cholesterol synthesis and
    efflux/influx but miR-33a decreases cholesterol efflux. MVK mevalonate kinase;
    MVD mevalonate diphosphate decarboxylase; PMVK phosphomevalonate kinase; FPPS
    farnesylpyrophosphate synthase; SQS squalene synthase; SQLE squalene epoxidase;
    LSS lanosterol synthase
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pten
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - SREBP
  - p53
  - betaTub60D
  - hth
  - Hmgcr
  - Mvk
  - Mvd
  - Pmvk
  - Fpps
  - yki
  - Taz
  - Dis3
  - PTEN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - TP53
  - TP63
  - TP73
  - SREBF2
  - MIR33A
  - HMGCR
  - MVK
  - MVD
  - PMVK
  - FDPS
  - FDFT1
  - SQLE
  - LSS
  - LMBR1
  - TAFAZZIN
  - WWTR1
  - YAP1
  - NR1H2
  - NR1H3
---
